Previous Article | Next Article 
Journal of Virology, March 2007, p. 2149-2157, Vol. 81, No. 5
0022-538X/07/$08.00+0 doi:10.1128/JVI.02302-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Vaccinia Virus 4c (A26L) Protein on Intracellular Mature Virus Binds to the Extracellular Cellular Matrix Laminin
Wen-Ling Chiu,1,
Chi-Long Lin,1,
Min-Hsiang Yang,2
Der-Lii M. Tzou,2 and
Wen Chang1*
Institute of Molecular Biology,1
Institute of Chemistry, Academia Sinica, Taipei, Taiwan, Republic of China2
Received 20 October 2006/
Accepted 1 December 2006
Vaccinia virus intracellular mature virus (IMV) binds to glycosaminoglycans (GAGs) on cells via three virion proteins, H3L, A27L, and D8L. In this study, we demonstrated that binding of IMV to BSC40 cells was competitively inhibited by soluble laminin but not by fibronectin or collagen V, suggesting that this cell surface extracellular matrix (ECM) protein may play a role in vaccinia virus entry. Moreover, IMV infection of GAG sog9 cells was also inhibited by laminin, demonstrating that virion binding to laminin does not involve a prior interaction with GAGs. Furthermore, comparative envelope protein analyses of wild-type vaccinia virus strain Western Reserve, which binds to laminin, and of a mutant virus, IA27L, which does not, showed that the A26L open reading frame (ORF), encoding an envelope protein, was mutated in IA27L, resulting in A26L being absent from the IMV. Expression of the wild-type A26L ORF in IA27L resulted in laminin binding activity. Moreover, recombinant A26L protein bound to laminin in vitro with a high affinity, providing direct evidence that A26L is the laminin binding protein on IMV. In summary, these results reveal a novel role for the vaccinia viral envelope protein A26L in binding to the ECM protein laminin, an association that is proposed to facilitate IMV entry.
* Corresponding author. Mailing address: Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China. Phone: 886-2-2789-9230. Fax: 886-2-2782-6085. E-mail:
mbwen{at}ccvax.sinica.edu.tw.
Published ahead of print on 13 December 2006.
Both authors contributed equally to the work.
Journal of Virology, March 2007, p. 2149-2157, Vol. 81, No. 5
0022-538X/07/$08.00+0 doi:10.1128/JVI.02302-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Laliberte, J. P., Moss, B.
(2009). Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry. Proc. Natl. Acad. Sci. USA
106: 17517-17521
[Abstract]
[Full Text]
-
Ching, Y.-C., Chung, C.-S., Huang, C.-Y., Hsia, Y., Tang, Y.-L., Chang, W.
(2009). Disulfide Bond Formation at the C Termini of Vaccinia Virus A26 and A27 Proteins Does Not Require Viral Redox Enzymes and Suppresses Glycosaminoglycan-Mediated Cell Fusion. J. Virol.
83: 6464-6476
[Abstract]
[Full Text]
-
Howard, A. R., Senkevich, T. G., Moss, B.
(2008). Vaccinia Virus A26 and A27 Proteins Form a Stable Complex Tethered to Mature Virions by Association with the A17 Transmembrane Protein. J. Virol.
82: 12384-12391
[Abstract]
[Full Text]
-
Nichols, R. J., Stanitsa, E., Unger, B., Traktman, P.
(2008). The Vaccinia Virus Gene I2L Encodes a Membrane Protein with an Essential Role in Virion Entry. J. Virol.
82: 10247-10261
[Abstract]
[Full Text]
-
Huang, C.-Y., Lu, T.-Y., Bair, C.-H., Chang, Y.-S., Jwo, J.-K., Chang, W.
(2008). A Novel Cellular Protein, VPEF, Facilitates Vaccinia Virus Penetration into HeLa Cells through Fluid Phase Endocytosis. J. Virol.
82: 7988-7999
[Abstract]
[Full Text]
-
Campo, G. M., Avenoso, A., Campo, S., D'Ascola, A., Traina, P., Sama, D., Calatroni, A.
(2008). Purified human plasma glycosaminoglycans reduced NF-{kappa}B activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immunity
14: 233-246
[Abstract]
-
Nelson, G. E., Wagenaar, T. R., Moss, B.
(2008). A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity. J. Virol.
82: 6244-6250
[Abstract]
[Full Text]
-
Benhnia, M. R.-E.-I., McCausland, M. M., Su, H.-P., Singh, K., Hoffmann, J., Davies, D. H., Felgner, P. L., Head, S., Sette, A., Garboczi, D. N., Crotty, S.
(2008). Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine. J. Virol.
82: 3751-3768
[Abstract]
[Full Text]